G. Roland

In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). A quinolone with high activity against gram-positive bacteria.

M. Cohen, S. Yoder, M. Huband, 1991, Diagnostic microbiology and infectious disease.

In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci

M. Cohen, S. Yoder, M. Huband, 1995, Antimicrobial agents and chemotherapy.

In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391.

M. Cohen, S. Yoder, M. Huband, 1991, Diagnostic microbiology and infectious disease.

Inhibition of the Staphylococcus aureusNADPH-dependent Enoyl-Acyl Carrier Protein Reductase by Triclosan and Hexachlorophene*

R. Heath, C. Rock, G. E. Roland, 2000, The Journal of Biological Chemistry.

In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent

M. Cohen, S. Yoder, J. Domagala, 1991, Antimicrobial Agents and Chemotherapy.

Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity.

M. Cohen, J. Domagala, M. Suto, 1992, Journal of medicinal chemistry.